This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Anacor Pharmaceuticals Inc
ANAC : NASDAQ : Health Care
$24.51 -0.30 | -1.21%
Today's Range: 24.13 - 24.58
Avg. Daily Volume: 563,700
09/22/14 - 2:55 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
ANAC ANACOR PHARMACEUTICALS INC 24.77 1040.24 16.40 19.19 76.12
IMGN IMMUNOGEN INC 11.34 974.20 n/m 59.90 68.55
CMRX CHIMERIX INC 27.21 970.55 n/m 3.49 35.32
ARNA ARENA PHARMACEUTICALS INC 4.27 938.70 n/m 29.71 -60.25
INSY INSYS THERAPEUTICS INC 34.07 1175.76 22.97 166.74 319.04
PTLA PORTOLA PHARMACEUTICALS INC 27.13 1123.10 n/m 9.61 269.39
ARIA ARIAD PHARMACEUTICALS INC 5.76 1077.19 n/m 48.98 137.36
NVAX NOVAVAX INC 4.48 1068.09 n/m 29.27 65.41
LGND LIGAND PHARMACEUTICAL INC 50.79 1055.47 145.11 54.31 31.68
BLUE BLUEBIRD BIO INC 36.00 1029.46 n/m 25.39 300.85
AEGR AEGERION PHARMACEUTICALS INC 34.10 1007.55 n/m 103.81 1244.54
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

ANAC Ind Avg S&P 500
16.40 82.53 19.94
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs